Transfer factor (its use in immunotherapy of neoplasms and other diseases)
Zduńczyk, A.
Wiadomosci Lekarskie 33(11): 877-881
1980
ISSN/ISBN: 0043-5147 PMID: 6999743 Document Number: 161923
Document emailed within 1 workday
Related Documents
Burger, D.R.; Vetto, R.M.; Vandenbark, A.A. 1974: Transfer factor immunotherapy in human cancer Surgical Forum 25: 93-95Fujisawa, T. 1985: Transfer factor immunotherapy as an adjunct to surgery in lung cancer Nihon Kyobu Shikkan Gakkai Zasshi 23(1): 68-73
Trepel, F. 1971: Immunotherapy of neoplasms Medizinische Klinik 66(7): 222-229
Brandes, L.J.; Goldenberg, G.J. 1974: In vitro transfer of cellular immunity against nasopharyngeal carcinoma using transfer factor from donors with Epstein-Barr virus antibody activity Cancer Research 34(11): 3095-3101
Diaz-Rubio García, E. 1975: Current status of immunotherapy in neoplasms Revista Clinica Espanola 139(6): 487-496
Matthias, M. 1975: Chemo- and immunotherapy of malignant neoplasms Zeitschrift für Arztliche Fortbildung 69(11): 580-584
Mellstedt, H.åk.; Veelken, H. 2005: Active immunotherapy in patients with hematologic and solid neoplasms Onkologie 28(Suppl 4): 4-8
Hashimoto, Y.; Nishimura, T. 1979: Immunotherapy of neoplasms, with special reference to the destruction of neoplastic cells Nihon Rinsho. Japanese Journal of Clinical Medicine 37(7): 2872-2877
Grinevich, I.A. 1991: Nonspecific active immunotherapy in the combined treatment of malignant neoplasms Vrachebnoe Delo 5: 8-11
Sugimachi, K.; Ageo, H.; Natsuda, Y.; Yasaka, A.; Nakamura, T. 1979: Postoperative long-term chemotherapy combined with immunotherapy in esophageal neoplasms Nihon Kyobu Geka Gakkai 27(4): 504-506
Carballido, J.; Alvarez-Mon, M.; Olivier, C.; Moltó, L. 1990: Immunotherapy of urothelial neoplasms. Experimental and clinical implications of alpha interferon Archivos Espanoles de Urologia 43(Suppl 2): 149-158
Check, J.H.; Liss, J.; Check, M.L.; Diantonio, A.; Choe, J.K.; Graziano, V. 2005: Leukocyte immunotherapy improves live delivery rates following embryo transfer in women with at least two previous failures: a retrospective review Clinical and Experimental Obstetrics and Gynecology 32(2): 85-88
Kobayashi, N.; Akiya, M. 1980: Bedside conference in pediatric nursing. 10. The nursing of children with respiratory diseases (No. 3), neurologic diseases (No. 2), malignant neoplasms (No. 3), hematologic diseases (No. 5) and kidney Kango Tenbo. Japanese Journal of Nursing Science 5(10): 922-933
Abu-Jawdeh, G.M.; Faix, J.D.; Niloff, J.; Tognazzi, K.; Manseau, E.; Dvorak, H.F.; Brown, L.F. 1996: Strong expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in ovarian borderline and malignant neoplasms Laboratory Investigation; A Journal of Technical Methods and Pathology 74(6): 1105-1115
Riera, L.; Koziner, B. 2000: Donor lymphocyte infusions as adoptive immunotherapy in patients with relapsed hematologic neoplasms post-allogenic transplant of hematopoietic progenitor cells Medicina 60(2): 259-269
Chang, J.M.; Johnson, G.R. 1991: Effects on spleen colony-forming unit self-renewal after retroviral-mediated gene transfer of multi-colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or granulocyte colony-stimulating factor Experimental Hematology 19(7): 602-607
Kvasnicka, J.; Richter, J.; Pekárek, J.; Rennerová, J. 1980: Transfer factor Casopis Lekaru Ceskych 119(52): 1427-1430
Fong, K.Y. 2002: Immunotherapy in autoimmune diseases Annals of the Academy of Medicine Singapore 31(6): 702-706
Mochizuki, M. 1992: Immunotherapy in ocular diseases Nippon Ganka Gakkai Zasshi 96(12): 1608-1634
Romański, B. 1984: Specific immunotherapy of atopic diseases Polski Tygodnik Lekarski 39(31): 1021-1026